Clinical Trial Update: Daratumumab for T Cell ALL With MRD-positive After Standard Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating daratumumab for adults with MRD-positive T-cell acute lymphoblastic leukemia after standard chemotherapy; the study status is NOT_YET_R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: ALL, Adult | Phase 2 | Status: NOT_YET_RECRUITING